- Home
- COYA vs RFM Comparison
COYA vs RFM Comparison
Compare COYA & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- RFM
- Stock Information
- Founded
- COYA 2020
- RFM 2020
- Country
- COYA United States
- RFM United States
- Employees
- COYA N/A
- RFM N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- RFM Finance/Investors Services
- Sector
- COYA Health Care
- RFM Finance
- Exchange
- COYA Nasdaq
- RFM Nasdaq
- Market Cap
- COYA 99.8M
- RFM 86.8M
- IPO Year
- COYA 2022
- RFM N/A
- Fundamental
- Price
- COYA $5.66
- RFM $14.11
- Analyst Decision
- COYA Strong Buy
- RFM
- Analyst Count
- COYA 4
- RFM 0
- Target Price
- COYA $17.00
- RFM N/A
- AVG Volume (30 Days)
- COYA 36.0K
- RFM 20.7K
- Earning Date
- COYA 05-13-2025
- RFM 01-01-0001
- Dividend Yield
- COYA N/A
- RFM 9.74%
- EPS Growth
- COYA N/A
- RFM N/A
- EPS
- COYA N/A
- RFM N/A
- Revenue
- COYA $3,685,107.00
- RFM N/A
- Revenue This Year
- COYA $105.26
- RFM N/A
- Revenue Next Year
- COYA N/A
- RFM N/A
- P/E Ratio
- COYA N/A
- RFM N/A
- Revenue Growth
- COYA N/A
- RFM N/A
- 52 Week Low
- COYA $4.65
- RFM $12.89
- 52 Week High
- COYA $10.24
- RFM $16.41
- Technical
- Relative Strength Index (RSI)
- COYA 46.42
- RFM 46.04
- Support Level
- COYA $5.29
- RFM $14.00
- Resistance Level
- COYA $6.03
- RFM $14.18
- Average True Range (ATR)
- COYA 0.31
- RFM 0.12
- MACD
- COYA 0.03
- RFM -0.01
- Stochastic Oscillator
- COYA 51.32
- RFM 40.74
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.